TUDOR INVESTMENT CORP ET AL

Position in ANIK — Anika Therapeutics, Inc.

CIK 923093 STAMFORD, CT

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$334,105

+$227,368 QoQ

Shares Held

22,837

+101.1% QoQ

Ownership

0.171%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 134 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 50% Shared 50% None 0%

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $64,629,641 across 19 Drug Manufacturers - Specialty & Generic names. ANIK ranks #13 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	490,000	$16,601,200
2	ZTS	Zoetis Inc.	208,246	$14,964,557
3	HLN	Haleon plc	762,877	$7,117,642
4	UTHR	UNITED THERAPEUTICS Corp	12,667	$6,863,360
5	ELAN	Elanco Animal Health Inc	256,108	$6,302,817
6	HIMS	Hims & Hers Health, Inc.	128,796	$4,465,357
7	BCRX	Biocryst Pharmaceuticals Inc	195,128	$1,951,280
8	TAK	Takeda Pharmaceutical Co Ltd	100,149	$1,605,388

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$334,105	22,837	+101.1%	Shares	Defined	2026-08-14
2025-09-30	$106,737	11,355	-16.7%	Shares	Defined	2025-12-09
2025-03-31	$204,828	13,628	-62.1%	Shares	Defined	2025-05-15
2024-12-31	$592,378	35,989	+22.7%	Shares	Defined	2025-02-14
2024-09-30	$724,747	29,342	+2.5%	Shares	Defined	2024-11-14
2024-06-30	$725,121	28,627	-20.6%	Shares	Defined	2024-08-14
2024-03-31	$915,593	36,047	+48.0%	Shares	Defined	2024-05-15
2023-12-31	$552,020	24,361	-32.4%	Shares	Defined	2024-02-14
2023-09-30	$671,257	36,031	+8.6%	Shares	Defined	2023-11-15
2021-03-31	$1,353,616	33,185	+90.1%	Shares	Defined	2021-05-17
2020-12-31	$790,103	17,457	+41.6%	Shares	Defined	2021-02-16
2020-09-30	$436,323	12,329	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.